Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | atropine | 174174 | drug-path |
| Hedgehog signaling pathway | R-HSA-5358351 | map04340 | atropine | 174174 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | disopyramide | 3114 | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | disopyramide | 3114 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | disopyramide | 3114 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | disopyramide | 3114 | drug-path |
| Glioma | Q9NZM4 | map05214 | disopyramide | 3114 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | disopyramide | 3114 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | disopyramide | 3114 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | disopyramide | 3114 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | disopyramide | 3114 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | disopyramide | 3114 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | disopyramide | 3114 | drug-path |
| Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | disopyramide | 3114 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | disopyramide | 3114 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | disopyramide | 3114 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | disopyramide | 3114 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | disopyramide | 3114 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | disopyramide | 3114 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | disopyramide | 3114 | drug-path |